Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users
Public ClinicalTrials.gov record NCT04003805. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is focused on characterizing the toxic and carcinogenic potential of the Standardized Research E-cigarette (SREC) developed by the National Institute on Drug Abuse. In the environment of continuously changing e-cigarette market, SREC was developed as a model e-cigarette that will remain available for an extended period of time and can be used as a bridging element in various studies aimed at evaluating the value and limitations of e-cigarettes as tobacco risk reduction tools. Our overall goal is to generate initial reference data on chemical exposures and associated effects in smokers switching to SREC.
Study identification
- NCT ID
- NCT04003805
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 47 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 10, 2022
- Primary completion
- May 30, 2024
- Completion
- Aug 19, 2026
- Last update posted
- Jun 23, 2026
2022 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Minnesota, Masonic Cancer Center | Minneapolis | Minnesota | 55455 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Smoking, Cigarette trials
Other public records listing Smoking, Cigarette. Sorted by last update posted; newest first. Not a recommendation.
- NCT07771725: Impact of Sweeteners on the Addictive Threshold of Nicotine Not yet recruiting
- NCT07711691: Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+) Not yet recruiting
- NCT07661550: Prevention of Postpartum Smoking Relapse and Related Health Consequences by Breastfeeding Promotion Recruiting
- NCT07553962: Measuring Communal Coping in Dual-smoking Couples Making a Quit Attempt Recruiting
- NCT06296849: Dyadic Financial Incentive Treatments for Dual Smoker Couples Recruiting
- NCT07221214: GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04003805, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2026 · Synced Aug 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04003805 live on ClinicalTrials.gov.